Research news

A new technique allows researchers to focus the action of drugs via infrared light

A scientific team led by IBEC and UAB manages to efficiently activate molecules located inside cell tissues using two-photon excitation of with infrared light lasers. The results of the study has been published in Nature Communications.

Having absolute control of the activity of a molecule in an organism. Deciding when, where and how a drug is activated. These are some of the goals expected to be reached with the so-called photoswitchable molecules, compounds that, in the presence of certain light waves, change their properties. Today, thanks to the results of a study led by the Institute for Bioengineering of Catalonia (IBEC) together with the Universitat Autònoma de Barcelona (UAB), the scientific community is one step closer to achieving this objective.

Read more…

Other news

12th Annual Conference of Biomedical Research Technology Platforms

The Spanish Platform for Nanomedicine (NanoMedSpain) coordinated by Josep Samitier, director of IBEC, has participated once again in the Annual Conference of Technological Platforms of Biomedical Research that took place in Madrid during the days 5 an 6 of March.

This yearly conference, organised by the four national platforms Farmaindustria, Asebio, NanomedSpain and FENIN -Innovative medicines, nanomedicine, sanitary technology and biotechnological markets- where the main issue was how to boost biomedical research hubs in Spain. During the morning of the 5th of March, the directors of each platform presented a summary of their activity during 2018, after which their invited speakers gave talks. This year, NanomedSpain has invited Per Matsson, president of EIT Health Scandinavia and CTO at Thermo Fisher Scientific Immunodiagnostics whose speech was entitled “Innovation in health: from biomarker discovery to implementation”.

Read more…